ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 73 filers reported holding ARBUTUS BIOPHARMA CORP in Q1 2019. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $816,000 | -1.3% | 228,000 | +5.6% | 0.05% | -8.9% |
| Q4 2018 | $827,000 | +24.9% | 216,000 | +208.6% | 0.06% | +43.6% |
| Q3 2018 | $662,000 | -10.5% | 70,000 | -67.4% | 0.04% | -42.6% |
| Q3 2016 | $740,000 | -1.1% | 215,000 | 0.0% | 0.07% | -23.6% |
| Q2 2016 | $748,000 | -15.8% | 215,000 | 0.0% | 0.09% | -28.2% |
| Q1 2016 | $888,000 | -32.2% | 215,000 | 0.0% | 0.12% | -39.2% |
| Q3 2015 | $1,309,000 | – | 215,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 16,013,540 | $39,233,000 | 1.19% |
| ARMISTICE CAPITAL, LLC | 1,940,000 | $4,753,000 | 1.12% |
| DAFNA Capital Management LLC | 234,000 | $573,000 | 0.50% |
| Alpha Wave Global, LP | 1,655,162 | $4,055,000 | 0.43% |
| Telemetry Investments, L.L.C. | 150,000 | $368,000 | 0.21% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 5,294,945 | $12,972,000 | 0.18% |
| SABBY MANAGEMENT, LLC | 792,617 | $1,942,000 | 0.11% |
| K2 PRINCIPAL FUND, L.P. | 443,887 | $1,088,000 | 0.10% |
| Anson Funds Management LP | 105,085 | $257,000 | 0.08% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 25,000 | $61,000 | 0.03% |